HealthCare Global Enterprises Limited
HCG.NS
Get informed when a big investor buys or sells
+ FollowMarket Cap$89.03B
Close$
$631.40
7.2% upside
Current Fair Value
7.2% upsideUndervalued by 7.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $89.03 Billion |
|---|---|
| Enterprise Value | $89.03 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.97 |
| Beta | -0.04 |
| Outstanding Shares | 149,673,913 |
Return
| Return on Equity | 1.62% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 377.69 |
|---|---|
| PEG | 198.9 |
| Price to Sales | 3.37 |
| Price to Book Ratio | 6.27 |
| Enterprise Value to Revenue | 3.4 |
| Enterprise Value to EBIT | 42.19 |
| Enterprise Value to Net Income | 390 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$2.81
Average shareholder expectationRevenue Estimate
$7.03 B
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$2.27
Average shareholder expectationRevenue Estimate
$7.26 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About HealthCare Global Enterprises Limited
6,761 employees
CEO: Manish Mattoo HealthCare Global Enterprises Limited (HCG), along with its subsidiaries, delivers specialized healthcare services with a primary emphasis on oncology and fertility. The company's cancer division provides comprehensive care, encompassing...